Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aerosol Drug Delivery Through High Flow Nasal Cannula.

Literature DB >> 29256347

Aerosol Drug Delivery Through High Flow Nasal Cannula.

Abstract

BACKGROUND: High flow nasal cannula (HFNC) is widely utilized to support critically ill adults, pediatrics and neonates. Through the continuous delivery of oxygen at high flow rates that meet or exceed patients' inspiratory flow, HFNC improves oxygenation, respiratory rates, patient comfort, and tolerance during therapy. As HFNC becomes more widely employed, clinicians have started to consider aerosol drug delivery through HFNC.
CONCLUSION: Using HFNC along with nebulizers as a potential therapy in aerosol medicine is a new and innovative approach for aerosol drug delivery to patients with pulmonary diseases. The purpose of this paper is to review current in vitro and in vivo studies on aerosol drug delivery through HFNC in adults and children. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities: Chemical Disease Species

Keywords: Aerosols; adults; high flow nasal cannula; nebulizers; neonates.; pediatrics

Mesh：

Substances：

Year: 2017 PMID： 29256347 DOI： 10.2174/1389201019666171219104217

Source DB: PubMed Journal: Curr Pharm Biotechnol ISSN： 1389-2010 Impact factor: 2.837

Keyword Cloud
Cited

7 in total

Review 1. A path to successful patient outcomes through aerosol drug delivery to children: a narrative review.

Authors: Arzu Ari
Journal: Ann Transl Med Date: 2021-04

Review 2. A Narrative Review of a Pulmonary Aerosolized Formulation or a Nasal Drop Using Sera Containing Neutralizing Antibodies Collected from COVID-19-Recovered Patients as a Probable Therapy for COVID-19.

Authors: Nishat Fatima; Vichitra Kaushik; Amjad Ayoub
Journal: Iran J Med Sci Date: 2021-05

Review 3. Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems.

Authors: Ahmed A H Abdellatif; Hesham M Tawfeek; Ahmed Abdelfattah; Gaber El-Saber Batiha; Helal F Hetta
Journal: J Drug Deliv Sci Technol Date: 2021-02-19 Impact factor: 3.981

Review 4. How to deliver aerosolized medications through high flow nasal cannula safely and effectively in the era of COVID-19 and beyond: A narrative review.

Authors: Arzu Ari; Gerald B Moody
Journal: Can J Respir Ther Date: 2021-03-01

Aerosol Drug Delivery Through High Flow Nasal Cannula.

Review 1. A path to successful patient outcomes through aerosol drug delivery to children: a narrative review.

Review 2. A Narrative Review of a Pulmonary Aerosolized Formulation or a Nasal Drop Using Sera Containing Neutralizing Antibodies Collected from COVID-19-Recovered Patients as a Probable Therapy for COVID-19.

Review 3. Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems.

Review 4. How to deliver aerosolized medications through high flow nasal cannula safely and effectively in the era of COVID-19 and beyond: A narrative review.

Review 5. High-Flow Nasal Cannula Oxygen Therapy: Physiological Mechanisms and Clinical Applications in Children.

Review 6. A narrative review on trans-nasal pulmonary aerosol delivery.

Review 7. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19.